Randomized studies have firmly established the role of autologous transplant as initial therapy in multiple myeloma (MM). Indeed, MM has emerged as the commonest indication for autologous SCT in North America. The conceptual basis for high-dose therapy is the goal of complete remission (CR) ...
Despite significant advances in the treatment of multiple myeloma which had led to unprecedented rates of response and survival, patients still relapse, and cure remains elusive. We propose in this review a roadmap to achieve the dream of cure for multiple myeloma based on five complementary strate...
When patients respond well to treatment for multiple myeloma, doctors can’t tell them whether they’ve been cured. That news comes 10 years later, after the patients have been monitored carefully for recurrence. “During that time, you’re constantly watching and waiting for the second shoe...
Frontline therapy for multiple myeloma (MM) is evolving to include novel combinations that can achieve unprecedented deep response rates. Several treatment strategies exist, varying in induction regimen composition, use of transplant and or consolidation and maintenance. In this sea of different treatment...
In addition to to your fishing experience, each charter will be helping to find a cure for Multiple Myeloma, a type of bone cancer, through donations from your charter fee to the respective research foundations to increase awareness of this terrible disease. ...
“The MMRF is an exemplary organization dedicated to finding new treatments and ultimately a cure for multiple myeloma, a disease I have. It is truly worthy of support by all myeloma patients, their friends and families. If all myeloma patients contributed to myeloma research, maybe we’d have...
Initial versus deferred melphalan-prednisone therapy for asymptomatic multiple myeloma stage I - A randomized study From October 1983 until December 1988, 50 patients with asymptomatic multiple myeloma stage I were included in a prospective randomized multi-centre study ... Martin,Hjorth,Louise,... -...
Moving Mountains 4 Multiple Myeloma is an award-winning collaboration between the Multiple Myeloma Research Foundation (MMRF) and CURE to raise research funds, awareness and hope for myeloma patients. Patients, caregivers, myeloma doctors and nurses and myeloma loved ones take on challenging mountains ...
Export Citation for this Article Get Citation Alerts Request PermissionsAbstract References Cited By Get PDF (272K) Keywords: multiple myeloma cure; plasma cell disease Abstract A 52-year-old man with a plasmacytoma of the body of T-10 in February 1965 returned 6 months later with multiple myel...
This is a poem based on my personal interpretation of my husband’s experience while he cared for his mother with cancer. Read More The Solitude of Reality With Multiple Myeloma Judy Jones Brickner August 28th 2024 I was diagnosed with stage 1 multiple myeloma in 2018 and writing poetry helped...